 Better Therapeutics Inc, a company developing prescription-only smartphone-based treatments for Type 2 diabetes and high blood pressure, has agreed to go public through a merger with a blank-check company Mountain Crest Acquisition Corp II NASDAQ: MCAD The transaction is expected to close during this summer, and the combined entity will operate under the Better Therapeutics moniker and trade on the NASDAQ under the symbol BTTX. 